Global Weight Reduction Medicine Market report

Weight Reduction Medicine Comprehensive Study by Type (Diet Pills, Others), Application (Weight-Reducing Aid, Other), Distribution Channel (Multi-level marketing, Large retail, Small retail, Health and beauty stores, Online distribution), Form (Liquid, Tablets, Powder, Others) Players and Region - Global Market Outlook to 2030

Weight Reduction Medicine Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Weight Reduction Medicine
Weight reduction medicines are pharmacological drugs which are used to reduce the weight. These drugs alters the fundamental process of human body either by altering appetite or by reducing absorption of calories. Since these drugs provide benefit of losing weight they might impact on health. Hence the medical authorities have straighten rules on companies of it. Growing research and development and consciousness regarding health would help to grow weight reduction medicines in the long-standing.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Weight Reduction Medicine is a fragmented market due to the presence of less players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that China Vendors will contribute the maximum growth to Global Weight Reduction Medicine market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Lunan Pharmaceutical Group Corporation (China), Zein Pharmaceutical (China), China Zhongshan Pharm (China), Roche (Switzerland), Teva (Israel), National Company for Pharmaceutical Industry (Syria), Novo Nordisk (Denmark) and Eli Iilly (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Herbalife Nutrional Limited (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Weight Reduction Medicine market by Type (Diet Pills and Others), Application (Weight-Reducing Aid and Other) and Region.



On the basis of geography, the market of Weight Reduction Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel , the sub-segment i.e. Multi-level marketing will boost the Weight Reduction Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Liquid will boost the Weight Reduction Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Awareness for Weight Management

Market Growth Drivers:
All-inclusive Approach to Health and Increasing Health Consciousness

Challenges:
Misleading claims about possible outcomes and benefits

Restraints:
Side-Effects of Synthetic Supplement on Health

Opportunities:
Increasing Customer Interest in Health and Wellness

Market Leaders and their expansionary development strategies
In July 2023, Eli Lilly acquired Versanis, a privately held obesity drug maker, for up to USD 1.93 billion to expand its weight loss treatment portfolio.
In November 2023, Novo Nordisk pushing ahead with the launched weight-loss drug Wegovy in Europe and Japan, even as it struggles to keep up with the demand. The Danish drugmaker is working to convince European governments and insurers to reimburse the drug, seeking to a position it as more than a lifestyle drug.


Key Target Audience
Hospitals, Healthcare Institute, Research Institute, Government bodies, Business research and consulting firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Diet Pills
  • Others
By Application
  • Weight-Reducing Aid
  • Other
By Distribution Channel
  • Multi-level marketing
  • Large retail
  • Small retail
  • Health and beauty stores
  • Online distribution

By Form
  • Liquid
  • Tablets
  • Powder
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. All-inclusive Approach to Health
      • 3.2.2. Increasing Health Consciousness
    • 3.3. Market Challenges
      • 3.3.1. Misleading claims about possible outcomes and benefits
    • 3.4. Market Trends
      • 3.4.1. Rising Awareness for Weight Management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Weight Reduction Medicine, by Type, Application, Distribution Channel , Form and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Weight Reduction Medicine (Value)
      • 5.2.1. Global Weight Reduction Medicine by: Type (Value)
        • 5.2.1.1. Diet Pills
        • 5.2.1.2. Others
      • 5.2.2. Global Weight Reduction Medicine by: Application (Value)
        • 5.2.2.1. Weight-Reducing Aid
        • 5.2.2.2. Other
      • 5.2.3. Global Weight Reduction Medicine by: Form (Value)
        • 5.2.3.1. Liquid
        • 5.2.3.2. Tablets
        • 5.2.3.3. Powder
        • 5.2.3.4. Others
      • 5.2.4. Global Weight Reduction Medicine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Weight Reduction Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Lunan Pharmaceutical Group Corporation (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zein Pharmaceutical (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. China Zhongshan Pharm (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teva (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. National Company for Pharmaceutical Industry (Syria)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novo Nordisk (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eli Iilly (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Weight Reduction Medicine Sale, by Type, Application, Distribution Channel , Form and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Weight Reduction Medicine (Value)
      • 7.2.1. Global Weight Reduction Medicine by: Type (Value)
        • 7.2.1.1. Diet Pills
        • 7.2.1.2. Others
      • 7.2.2. Global Weight Reduction Medicine by: Application (Value)
        • 7.2.2.1. Weight-Reducing Aid
        • 7.2.2.2. Other
      • 7.2.3. Global Weight Reduction Medicine by: Form (Value)
        • 7.2.3.1. Liquid
        • 7.2.3.2. Tablets
        • 7.2.3.3. Powder
        • 7.2.3.4. Others
      • 7.2.4. Global Weight Reduction Medicine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Weight Reduction Medicine: by Type(USD Million)
  • Table 2. Weight Reduction Medicine Diet Pills , by Region USD Million (2018-2023)
  • Table 3. Weight Reduction Medicine Others , by Region USD Million (2018-2023)
  • Table 4. Weight Reduction Medicine: by Application(USD Million)
  • Table 5. Weight Reduction Medicine Weight-Reducing Aid , by Region USD Million (2018-2023)
  • Table 6. Weight Reduction Medicine Other , by Region USD Million (2018-2023)
  • Table 7. Weight Reduction Medicine: by Form(USD Million)
  • Table 8. Weight Reduction Medicine Liquid , by Region USD Million (2018-2023)
  • Table 9. Weight Reduction Medicine Tablets , by Region USD Million (2018-2023)
  • Table 10. Weight Reduction Medicine Powder , by Region USD Million (2018-2023)
  • Table 11. Weight Reduction Medicine Others , by Region USD Million (2018-2023)
  • Table 12. South America Weight Reduction Medicine, by Country USD Million (2018-2023)
  • Table 13. South America Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 14. South America Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 15. South America Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 16. South America Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 17. Brazil Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 18. Brazil Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 19. Brazil Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 20. Brazil Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 21. Argentina Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 22. Argentina Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 23. Argentina Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 24. Argentina Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 25. Rest of South America Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 27. Rest of South America Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 28. Rest of South America Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 29. Asia Pacific Weight Reduction Medicine, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 33. Asia Pacific Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 34. China Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 35. China Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 36. China Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 37. China Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 38. Japan Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 39. Japan Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 40. Japan Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 41. Japan Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 42. India Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 43. India Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 44. India Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 45. India Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 46. South Korea Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 47. South Korea Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 48. South Korea Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 49. South Korea Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 50. Taiwan Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 51. Taiwan Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 52. Taiwan Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 53. Taiwan Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 54. Australia Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 55. Australia Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 56. Australia Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 57. Australia Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 62. Europe Weight Reduction Medicine, by Country USD Million (2018-2023)
  • Table 63. Europe Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 64. Europe Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 65. Europe Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 66. Europe Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 67. Germany Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 68. Germany Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 69. Germany Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 70. Germany Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 71. France Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 72. France Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 73. France Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 74. France Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 75. Italy Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 76. Italy Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 77. Italy Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 78. Italy Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 79. United Kingdom Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 80. United Kingdom Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 81. United Kingdom Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 82. United Kingdom Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 83. Netherlands Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 84. Netherlands Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 85. Netherlands Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 86. Netherlands Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 87. Rest of Europe Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 88. Rest of Europe Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 89. Rest of Europe Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 90. Rest of Europe Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 91. MEA Weight Reduction Medicine, by Country USD Million (2018-2023)
  • Table 92. MEA Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 93. MEA Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 94. MEA Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 95. MEA Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 96. Middle East Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 97. Middle East Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 98. Middle East Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 99. Middle East Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 100. Africa Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 101. Africa Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 102. Africa Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 103. Africa Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 104. North America Weight Reduction Medicine, by Country USD Million (2018-2023)
  • Table 105. North America Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 106. North America Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 107. North America Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 108. North America Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 109. United States Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 110. United States Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 111. United States Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 112. United States Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 113. Canada Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 114. Canada Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 115. Canada Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 116. Canada Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 117. Mexico Weight Reduction Medicine, by Type USD Million (2018-2023)
  • Table 118. Mexico Weight Reduction Medicine, by Application USD Million (2018-2023)
  • Table 119. Mexico Weight Reduction Medicine, by Distribution Channel USD Million (2018-2023)
  • Table 120. Mexico Weight Reduction Medicine, by Form USD Million (2018-2023)
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Weight Reduction Medicine: by Type(USD Million)
  • Table 130. Weight Reduction Medicine Diet Pills , by Region USD Million (2025-2030)
  • Table 131. Weight Reduction Medicine Others , by Region USD Million (2025-2030)
  • Table 132. Weight Reduction Medicine: by Application(USD Million)
  • Table 133. Weight Reduction Medicine Weight-Reducing Aid , by Region USD Million (2025-2030)
  • Table 134. Weight Reduction Medicine Other , by Region USD Million (2025-2030)
  • Table 135. Weight Reduction Medicine: by Form(USD Million)
  • Table 136. Weight Reduction Medicine Liquid , by Region USD Million (2025-2030)
  • Table 137. Weight Reduction Medicine Tablets , by Region USD Million (2025-2030)
  • Table 138. Weight Reduction Medicine Powder , by Region USD Million (2025-2030)
  • Table 139. Weight Reduction Medicine Others , by Region USD Million (2025-2030)
  • Table 140. South America Weight Reduction Medicine, by Country USD Million (2025-2030)
  • Table 141. South America Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 142. South America Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 143. South America Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 144. South America Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 145. Brazil Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 146. Brazil Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 147. Brazil Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 148. Brazil Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 149. Argentina Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 150. Argentina Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 151. Argentina Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 152. Argentina Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 153. Rest of South America Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 154. Rest of South America Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 155. Rest of South America Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 156. Rest of South America Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 157. Asia Pacific Weight Reduction Medicine, by Country USD Million (2025-2030)
  • Table 158. Asia Pacific Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 159. Asia Pacific Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 160. Asia Pacific Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 161. Asia Pacific Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 162. China Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 163. China Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 164. China Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 165. China Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 166. Japan Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 167. Japan Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 168. Japan Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 169. Japan Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 170. India Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 171. India Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 172. India Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 173. India Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 174. South Korea Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 175. South Korea Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 176. South Korea Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 177. South Korea Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 178. Taiwan Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 179. Taiwan Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 180. Taiwan Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 181. Taiwan Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 182. Australia Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 183. Australia Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 184. Australia Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 185. Australia Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 186. Rest of Asia-Pacific Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 187. Rest of Asia-Pacific Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 188. Rest of Asia-Pacific Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 189. Rest of Asia-Pacific Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 190. Europe Weight Reduction Medicine, by Country USD Million (2025-2030)
  • Table 191. Europe Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 192. Europe Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 193. Europe Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 194. Europe Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 195. Germany Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 196. Germany Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 197. Germany Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 198. Germany Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 199. France Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 200. France Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 201. France Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 202. France Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 203. Italy Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 204. Italy Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 205. Italy Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 206. Italy Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 207. United Kingdom Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 208. United Kingdom Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 209. United Kingdom Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 210. United Kingdom Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 211. Netherlands Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 212. Netherlands Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 213. Netherlands Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 214. Netherlands Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 215. Rest of Europe Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 216. Rest of Europe Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 217. Rest of Europe Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 218. Rest of Europe Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 219. MEA Weight Reduction Medicine, by Country USD Million (2025-2030)
  • Table 220. MEA Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 221. MEA Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 222. MEA Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 223. MEA Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 224. Middle East Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 225. Middle East Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 226. Middle East Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 227. Middle East Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 228. Africa Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 229. Africa Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 230. Africa Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 231. Africa Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 232. North America Weight Reduction Medicine, by Country USD Million (2025-2030)
  • Table 233. North America Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 234. North America Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 235. North America Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 236. North America Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 237. United States Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 238. United States Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 239. United States Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 240. United States Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 241. Canada Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 242. Canada Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 243. Canada Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 244. Canada Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 245. Mexico Weight Reduction Medicine, by Type USD Million (2025-2030)
  • Table 246. Mexico Weight Reduction Medicine, by Application USD Million (2025-2030)
  • Table 247. Mexico Weight Reduction Medicine, by Distribution Channel USD Million (2025-2030)
  • Table 248. Mexico Weight Reduction Medicine, by Form USD Million (2025-2030)
  • Table 249. Research Programs/Design for This Report
  • Table 250. Key Data Information from Secondary Sources
  • Table 251. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Weight Reduction Medicine: by Type USD Million (2018-2023)
  • Figure 5. Global Weight Reduction Medicine: by Application USD Million (2018-2023)
  • Figure 6. Global Weight Reduction Medicine: by Form USD Million (2018-2023)
  • Figure 7. South America Weight Reduction Medicine Share (%), by Country
  • Figure 8. Asia Pacific Weight Reduction Medicine Share (%), by Country
  • Figure 9. Europe Weight Reduction Medicine Share (%), by Country
  • Figure 10. MEA Weight Reduction Medicine Share (%), by Country
  • Figure 11. North America Weight Reduction Medicine Share (%), by Country
  • Figure 12. Global Weight Reduction Medicine share by Players 2023 (%)
  • Figure 13. Global Weight Reduction Medicine share by Players (Top 3) 2023(%)
  • Figure 14. Global Weight Reduction Medicine share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Lunan Pharmaceutical Group Corporation (China) Revenue, Net Income and Gross profit
  • Figure 17. Lunan Pharmaceutical Group Corporation (China) Revenue: by Geography 2023
  • Figure 18. Zein Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 19. Zein Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 20. China Zhongshan Pharm (China) Revenue, Net Income and Gross profit
  • Figure 21. China Zhongshan Pharm (China) Revenue: by Geography 2023
  • Figure 22. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Roche (Switzerland) Revenue: by Geography 2023
  • Figure 24. Teva (Israel) Revenue, Net Income and Gross profit
  • Figure 25. Teva (Israel) Revenue: by Geography 2023
  • Figure 26. National Company for Pharmaceutical Industry (Syria) Revenue, Net Income and Gross profit
  • Figure 27. National Company for Pharmaceutical Industry (Syria) Revenue: by Geography 2023
  • Figure 28. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 29. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 30. Eli Iilly (United States) Revenue, Net Income and Gross profit
  • Figure 31. Eli Iilly (United States) Revenue: by Geography 2023
  • Figure 32. Global Weight Reduction Medicine: by Type USD Million (2025-2030)
  • Figure 33. Global Weight Reduction Medicine: by Application USD Million (2025-2030)
  • Figure 34. Global Weight Reduction Medicine: by Form USD Million (2025-2030)
  • Figure 35. South America Weight Reduction Medicine Share (%), by Country
  • Figure 36. Asia Pacific Weight Reduction Medicine Share (%), by Country
  • Figure 37. Europe Weight Reduction Medicine Share (%), by Country
  • Figure 38. MEA Weight Reduction Medicine Share (%), by Country
  • Figure 39. North America Weight Reduction Medicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Lunan Pharmaceutical Group Corporation (China)
  • Zein Pharmaceutical (China)
  • China Zhongshan Pharm (China)
  • Roche (Switzerland)
  • Teva (Israel)
  • National Company for Pharmaceutical Industry (Syria)
  • Novo Nordisk (Denmark)
  • Eli Iilly (United States)
Additional players considered in the study are as follows:
Herbalife Nutrional Limited (United States) , Others
Select User Access Type

Key Highlights of Report


Jan 2024 250 Pages 83 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Weight Reduction Medicine Market report Quantitative research analysis
Global Weight Reduction Medicine Market report Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Lunan Pharmaceutical Group Corporation (China), Zein Pharmaceutical (China), China Zhongshan Pharm (China), Roche (Switzerland), Teva (Israel), National Company for Pharmaceutical Industry (Syria), Novo Nordisk (Denmark) and Eli Iilly (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Awareness for Weight Management" is seen as one of major influencing trends for Weight Reduction Medicine Market during projected period 2023-2030.
The Weight Reduction Medicine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Weight Reduction Medicine Market report Report?

Have a Query? Click Here

Other Related Reports

Drug Discovery Technologies Comprehensive Study by Technology (Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, Others), End...
$ 3650
Orthodontic Supplies Comprehensive Study by Type (Fixed Braces, Removable Braces, Adhesives), Bracket (Conventional Brackets, Self-ligating Brackets, Lingual Brackets), Material (Metal/Traditional Br...
$ 3450
Pharmacy Retail Comprehensive Study by Type (Generic Drugs, OTC Medicines, Patented Drugs), Product Type (Over the counter Products, Prescription Medical), Channel (Online, Offline), End User (Pharma...
$ 3500
Indocyanine Green Comprehensive Study by Application (Ophthalmology, Neurosurgery, Liver Diseases, Others), Dosage Consideration (Hepatic Impairment, Renal Impairment), End Users (Neonates and Infant...
$ 3650
Drug Delivery Comprehensive Study by Application (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topica...
$ 3750
Nicotine Polacrilex Comprehensive Study by Type (High Purity, Low Purity), Application (Nicotine Polacrilex Gum, Nicotine Polacrilex Lozenge, Other), Distribution Channel (Brick and Mortar Drug Store...
$ 3650